Last updated: 9 August 2024 at 8:06pm EST

Dr. Michel Detheux Net Worth




The estimated Net Worth of Michel Detheux is at least 7.95 百万$ dollars as of 18 April 2022. Dr Detheux owns over 11,500 units of iTeos Therapeutics stock worth over 603,830$ and over the last 4 years he sold ITOS stock worth over 6,511,822$. In addition, he makes 833,750$ as Pres、 CEO & Director at iTeos Therapeutics.

Dr Detheux ITOS stock SEC Form 4 insiders trading

Dr has made over 14 trades of the iTeos Therapeutics stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 11,500 units of ITOS stock worth 48,645$ on 18 April 2022.

The largest trade he's ever made was selling 44,500 units of iTeos Therapeutics stock on 2 December 2021 worth over 1,982,030$. On average, Dr trades about 10,533 units every 15 days since 2020. As of 18 April 2022 he still owns at least 37,763 units of iTeos Therapeutics stock.

You can see the complete history of Dr Detheux stock trades at the bottom of the page.





Dr. Michel Detheux biography

Dr. Michel Detheux is the Pres, CEO & Director at iTeos Therapeutics.

What is the salary of Dr Detheux?

As the Pres、 CEO & Director of iTeos Therapeutics, the total compensation of Dr Detheux at iTeos Therapeutics is 833,750$. There are no executives at iTeos Therapeutics getting paid more.



How old is Dr Detheux?

Dr Detheux is 54, he's been the Pres、 CEO & Director of iTeos Therapeutics since . There are 1 older and 3 younger executives at iTeos Therapeutics. The oldest executive at iTeos Therapeutics, Inc. is Dr. Michel Detheux Ph.D., 55, who is the Pres, CEO & Director.

What's Dr Detheux's mailing address?

Michel's mailing address filed with the SEC is C/O ITEOS THERAPEUTICS, INC., 321 ARSENAL STREET, WATERTOWN, MA, 02472.

Insiders trading at iTeos Therapeutics

Over the last 4 years, insiders at iTeos Therapeutics have traded over 196,492,023$ worth of iTeos Therapeutics stock and bought 4,975,000 units worth 95,182,800$ . The most active insiders traders include Capital Management, L.P.Ra ...Capital Management, L.P.Kol...Aaron I. Davis. On average, iTeos Therapeutics executives and independent directors trade stock every 12 days with the average trade being worth of 1,817,279$. The most recent stock trade was executed by Matthew Gall on 12 October 2023, trading 5,000 units of ITOS stock currently worth 41,850$.



What does iTeos Therapeutics do?

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2a receptor that is an open-label Phase 1/2a clinical trial in adult patients; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2a clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Cambridge, Massachusetts.



What does iTeos Therapeutics's logo look like?

iTeos Therapeutics, Inc. logo

Complete history of Dr Detheux stock trades at iTeos Therapeutics

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
18 Apr 2022 Michel Detheux
Chief Executive Officer
オプション行使 11,500 4.23$ 48,645$
18 Apr 2022
37,763
21 Mar 2022 Michel Detheux
Chief Executive Officer
販売 18,437 34.17$ 629,992$
21 Mar 2022
26,263
23 Feb 2022 Michel Detheux
Chief Executive Officer
販売 14,500 34.34$ 497,930$
23 Feb 2022
34,700
25 Jan 2022 Michel Detheux
Chief Executive Officer
販売 14,500 35.68$ 517,360$
25 Jan 2022
49,200
2 Dec 2021 Michel Detheux
Chief Executive Officer
販売 44,500 44.54$ 1,982,030$
2 Dec 2021
63,700
22 Nov 2021 Michel Detheux
Chief Executive Officer
オプション行使 16,263 12.45$ 202,474$
22 Nov 2021
92,700
1 Nov 2021 Michel Detheux
Chief Executive Officer
販売 20,557 28.55$ 586,902$
1 Nov 2021
76,437
21 Oct 2021 Michel Detheux
Chief Executive Officer
販売 196 28.00$ 5,488$
21 Oct 2021
96,994
15 Oct 2021 Michel Detheux
Chief Executive Officer
販売 1,836 28.01$ 51,426$
15 Oct 2021
97,190
23 Sep 2021 Michel Detheux
Chief Executive Officer
販売 6,411 28.14$ 180,406$
23 Sep 2021
99,026
1 Sep 2021 Michel Detheux
Chief Executive Officer
販売 20,252 28.66$ 580,422$
1 Sep 2021
105,437
27 Aug 2021 Michel Detheux
Chief Executive Officer
販売 14,663 28.13$ 412,470$
27 Aug 2021
125,689
23 Aug 2021 Michel Detheux
Chief Executive Officer
販売 8,585 28.06$ 240,895$
23 Aug 2021
140,352
14 Jun 2021 Michel Detheux
Chief Executive Officer
販売 29,000 28.50$ 826,500$
14 Jun 2021
148,937


iTeos Therapeutics executives and stock owners

iTeos Therapeutics executives and other stock owners filed with the SEC include: